A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

NCT05648448 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

Influenza
Influenza, Human

Interventions

DRUG: Oseltamivir
DRUG: Favipiravir
DRUG: Zanamivir
DRUG: Baloxavir
DRUG: Molnupiravir
DRUG: Peramivir
DRUG: Laninamivir
DRUG: Oseltamivir and Baloxavir
DRUG: Oseltamivir and Favipiravir
DRUG: Favipiravir and Baloxavir

Sponsor

University of Oxford